MoonLake Immunotherapeutics (MLTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of MLTX. The 7-day demo opens the 1M and 3M ranges and puts MLTX on your watchlist.
Start 7-day demoLatest MLTX insider trades
About MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics is an SEC registrant, filing under CIK 0001821586, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
MLTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 113,353 | $2.27M |
MLTX insider transactions (Form 4)
834 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Catherine Moukheibir - Director | Option exercise | Class A ordinary shares, par value $0.0001 per share | 23,500 | $0.00 | - | |
| Catherine Moukheibir - Director | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 23,500 | $48.79 | $1.15M | |
| Catherine Moukheibir - Director | Option exercise | Option to Buy | 23,500 | $0.00 | - | |
| BVF PARTNERS L P - Director | Grant or award | Option to Buy | 6,682 | $0.00 | - | |
| Simon Sturge - Director | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 171,000 | $53.72 | $9.19M | |
| BVF PARTNERS L P - Director | Open-market sale | Class A Ordinary Shares, $0.0001 par value | 1,030,589 | $50.00 | $51.53M | |
| BVF PARTNERS L P - Director | Open-market sale | Class A Ordinary Shares, $0.0001 par value | 836,862 | $50.00 | $41.84M | |
| BVF PARTNERS L P - Director | Open-market sale | Class A Ordinary Shares, $0.0001 par value | 132,549 | $50.00 | $6.63M |
Recent MLTX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
MLTX insider trading FAQ
What is the latest insider trade for MLTX?
MoonLake Immunotherapeutics (MLTX) had 4 insider filings in the last 90 days, with the most recent on 2026-07-29. The full record for MLTX runs to 34 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MLTX stock?
No insider purchases of MLTX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling MLTX stock?
5 insider sales of MLTX were filed in the last 90 days, totaling $2.27M.
Where can I see MLTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MLTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - da Silva Jorge Santos view on EDGAR
- - da Silva Jorge Santos view on EDGAR
- - Matthias Bodenstedt view on EDGAR
- - BVF PARTNERS L P view on EDGAR
- - Matthias Bodenstedt view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where MLTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MLTX with a 7-day demo
- MLTX on your watchlist
- Every MLTX Form 4 filing on record
- Up to 3 months of MLTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
